All our work to date has had the same purpose, which was to...

All our work to date has had the same purpose, which was to strengthen our position in relation to dealing with potential commercial partners. We have now established a substantial knowledge base and presented our findings to the world’s major players in the areas of crop protection, public health, animal health and consumer products under non-disclosure agreements. We have since developed and signed multiple Material Transfer Agreements with potential partners, under which we have provided Flavocide and Qcide for their internal evaluation. These agreements outline mutually agreed specific testing protocols and target pests and give us a high level of control and assurance as to the type of testing being conducted, the sharing of results, and the protection of current and future Intellectual Property. In all cases, the testing has involved both compounds.

The approach to testing varies amongst the companies, some are focusing on a single major application while others are interested in broader screening as they look for the best opportunities.

During the year ahead we will continue to work with potential partners with the aim of advancing our technology towards commercial partnerships. We take this opportunity to thank our fellow Directors, our employees, our adviser to the Board Doug Rathbone, our scientific advisors and everyone that has worked with Bio-Gene during the past year for their valuable contribution.



Needless to say, BGT has been doing a massive amount of work behind the scenes. The stars are certainly aligning IMO

• The colony collapse global events demonstrating massive need for a bee friendly technology
• In talks with major players in all aspects of pest control
• Current cash in the bank amounting to enough for the several quarters
• A capital structure that can facilitate significant shareholder growth
• The top caliber team behind BGT